2013

• Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013), Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling. 91(1), 25-28. [Abstract]
• Kao, S., Vardy, J., Harvie, R., Chatfield, M., van Zandwijk, N., Clarke, S., Pavlakis, N. (2013), Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer. 21(3), 697-705. [Abstract]
• Kao, S., Clarke, S., Vardy, J., Corte, P., Clarke, C., van Zandwijk, N. (2013), Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales of Australia. Internal Medicine Journal. 43(4), 402-410. [Abstract]
• Kao, S., Vardy, J., Chatfield, M., Corte, P., Pavlakis, N., Clarke, C., van Zandwijk, N., Clarke, S. (2013), Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data From Patients Seeking Compensation From the New South Wales Dust Diseases Board. Clinical Lung Cancer. 14(1), 70-77. [Abstract]

2012

• Vardy, J., Pond, G., Dodd, A., Warr, D., Seruga, B., Clemons, M., Bordeleau, L., Goodwin, P., Tannock, I. (2012), A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 136(1), 143-151. [Abstract]
• Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012), Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Supportive Care in Cancer. 20(6), 1235-1242. [Abstract]
• Clarey, J., Kao, S., Clarke, S., Vardy, J. (2012), The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials. Annals of Oncology. 23(5), 1229-1233. [Abstract]
• Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012), Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology. 21(5), 496-504. [Abstract]
• Linton, A., Vardy, J., Clarke, S., van Zandwijk, N. (2012), The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology/Hematology. 84(2), 200-212. [Abstract]
• Fardell, J., Vardy, J., Shah, J., Johnston, I. (2012), Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology. 220(1), 183-193. [Abstract]
• Sharpe, M., Fardell, J., Vardy, J., Johnston, I. (2012), The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behavioural Brain Research. 227(1), 295-299. [Abstract]
• Ahles, T., Schagen, S., Vardy, J. (2012), Neurocognitive Effects of Anticancer Treatments. In: Clinical Psycho-Oncology: An International Perspective. (pp.71-82).United Kingdom: Wiley-Blackwell Publishing.
• Dhillon, H., van der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012), The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer. 12, 572. [Abstract]

2011

• Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology. 6(11), 1923-1929. [Abstract]
• Fardell, J., Vardy, J., Johnston, I., Winocur, G. (2011), Chemotherapy and Cognitive Impairment: Treatment Options. Clinical pharmacology and therapeutics. 90(3), 366-76. [Abstract]
• Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Tanious, M., Dong, S., Iedema, R., Vardy, J., Ashgari, R., Hui, R., Eisenbruch, M. (2011), Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(20), 2801-7. [Abstract]
• Wefel, J., Vardy, J., Ahles, T., Schagen, S. (2011), International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology. 12(7), 703-708. [Abstract]
• Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 43(4), 313-7. [Abstract]
• Kao, S., Yan, T., Lee, K., Burn, J., Henderson, D., Klebe, S., Kennedy, C., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(3), 602-605. [Abstract]
• Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology. 43(2), 128-132. [Abstract]
• Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011), Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC cancer. 11(1), 142. [Abstract]
• Vardy, J., Dhillon, H. (2011), Cognitive Function in Cancer Survivors. In: Supportive Oncology. (pp.448-454).United States: Elsevier.

2010

• Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010), High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research. 16(23), 5805-5813. [Abstract]
• Fardell, J., Vardy, J., Logge, W., Johnston, I. (2010), Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacology, biochemistry, and behavior. 97(2), 333-9. [Abstract]
• Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010), Malignant Mesothelioma. Internal Medicine Journal. 40(11), 742-750. [Abstract]
• Vardy, J., Dhillon, H. (2010), The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast cancer research and treatment. 123(1), 35-7. [Abstract]
• Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010), Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. Journal of the Society for Integrative Oncology. 8(2), 56-64. [Abstract]
• Kao, S., Butow, P., Bray, V., Clarke, S., Vardy, J. (2010), Patient and oncologist estimates of survival in advanced cancer patients. Psycho-Oncology. 0, 0.

2009

• Kao, S., Shafiq, J., Vardy, J., Adams, D. (2009), Use of chemotherapy at end of life in oncology patients. Annals of Oncology. 20(9), 1555-1559. [Abstract]
• Lai, J., Butt, Z., Wagner, L., Sweet, J., Beaumont, J., Vardy, J., Jacobsen, P., Shapiro, P., Jacobs, S., Cella, D. (2009), Evaluating the dimensionality of perceived cognitive function. Journal of Pain and Symptom Management. 37(6), 982-995. [Abstract]
• Vardy, J. (2009), Cognitive function in breast cancer survivors. In: Adjuvant Therapy for Breast Cancer. (pp.387-419).United States: Springer.
• Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009), Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC cancer. 9(1), 130. [Abstract]
• Vardy, J. (2009), Cognitive function in survivors of cancer. American Society of Clinical Oncology 2009 Education Book. 1, 570-574.
• Pollard, A., Eakin, E., Vardy, J., Hawkes, A. (2009), Health behaviour interventions for cancer survivors: An overview of the evidence and contemporary Australian trials. CancerForum. 33(3), 56-64.

2008

• Courneya, K., Booth, C., Gill, S., O'Brien, P., Vardy, J., Friedenreich, C., Au, H., Brundage, M., Tu, D., Dhillon, H., Meyer, R. (2008), The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Current Oncology. 15(6), 271-278. [Abstract]
• Vardy, J., Wefel, J., Ahles, T., Tannock, I., Schagen, S. (2008), Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 19(4), 623-9. [Abstract]
• Chiew, K., Shepherd, H., Vardy, J., Tattersall, M., Butow, P., Leighl, N. (2008), Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer. Health expectations. 11(1), 35-45. [Abstract]
• Vardy, J. (2008), Neurocognitive effects of chemotherapy in adults. Australian Prescriber. 31, 22-24.

2007

• Joly, F., Vardy, J., Pintilie, M., Tannock, I. (2007), Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of oncology. 18(12), 1935-1942. [Abstract]
• Schagen, S., Vardy, J. (2007), Cognitive dysfunction in people with cancer. The lancet oncology. 8(10), 852-3. [Abstract]
• Vardy, J., Tannock, I. (2007), Cognitive function after chemotherapy in adults with solid tumours. Critical reviews in oncology/hematology. 63(3), 183-202. [Abstract]
• Vardy, J., Rourke, S., Tannock, I. (2007), Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of clinical oncology. 25(17), 2455-2463. [Abstract]